Kahler said, “It is essential we take a more active role in the public policy issues shaping vital and innovative sectors. Our Washington, D.C. team will help foster and sustain beneficial dialogue with government and regulatory agencies.
Washington, DC (PRWEB) February 1, 2011
The RC Insight Group, a leading provider of global regulatory and clinical consulting services, competitive intelligence and strategic planning for the medical device and biotechnology industries, today announced the opening of its Washington, D.C. office and formation of its government policy group. Lori Kahler, President of The RC Insight Group, will oversee public policy initiatives and head the office.
Kahler founded The RC Insight Group in 2009. She was the Director of Quality and Regulatory Affairs for Heartlab, LLC (acquired by Agfa-Gevaert) from 2000 to 2005. From 2005 to 2007, she was Global Director of Quality Assurance and Regulatory Affairs of the Cardiovascular Business Unit for the Agfa Gevaert Group. Prior to her appointment at The RC Insight Group, Kahler was Vice President of Quality Assurance, Regulatory and Clinical Affairs for Ximedica, LLC from 2005 to 2007.
Founded in 2009, The RC Insight Group provides a broad spectrum of consulting support, from preclinical to commercialization and beyond. Under the leadership of regulatory affairs experts, their team works closely with innovative medical device and biotechnology industries and regulatory agencies around the world to promote a compliant, high quality, and efficient application and submission process. The RC Insight Group leverages their team’s collaborative experience with drugs, biologics, and devices (including combination products) to provide a comprehensive product development and regulatory strategy, drawing on scientific rigor and research excellence.
The RC Insight Group
5335 Wisconsin Avenue, NW, Suite 440
Washington, DC 20015-2052
Tel 202.715.6242 | Fax 202.686.2877